Traws Pharma, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$56K
$0
R&D↑+171.0% +$3M
$5M
D&A↑+2100.0% +$42K
$44K
Operating Income↑+52.5% +$4M
$-4M
EBITDA↑+2100.0% +$42K
$44K
Interest Expense
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
—
Net Income↑+53.3% +$5M
$-4M
Operating Margin↑+216354.3pts
-45.7%
Net Margin↑+216006.9pts
-33.5%
Effective Tax Rate
—
ETR (Continuing Operations)
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
0.5%
ETR Foreign Differential (pp)
0.1%
Revenue YoY Variation↓-100.0pts
-100.0%
Income YoY Variation↑+120.2pts
52.5%
Revenue QoQ Variation↓-100.0pts
-100.0%
Income QoQ Variation↓-317.7pts
-224.7%